T Böhler, I Herr, K M Debatin, M Geiss, J Haas. Show Affiliations »
Abstract
Entities: Disease Species
Mesh: See more » Anti-HIV Agents/therapeutic useCD4 Lymphocyte CountChildDidanosine/therapeutic useDrug Therapy, CombinationFas Ligand ProteinGene Expression Regulation/drug effectsHIV Infections/bloodHIV Infections/drug therapyHIV Infections/immunologyHIV-1/isolation & purificationHumansLamivudine/therapeutic useMembrane Glycoproteins/biosynthesisRNA, Messenger/biosynthesisReverse Transcriptase Inhibitors/therapeutic useT-Lymphocytes/drug effectsT-Lymphocytes/immunologyTime FactorsTranscription, Genetic/drug effectsZalcitabine/therapeutic useZidovudine/therapeutic usefas Receptor/immunology
Substances: See more » Anti-HIV AgentsFASLG protein, humanFas Ligand ProteinMembrane GlycoproteinsRNA, MessengerReverse Transcriptase Inhibitorsfas ReceptorLamivudineZidovudineZalcitabineDidanosine
Year: 1997 PMID: 9226190
Source DB: PubMed Journal: Blood ISSN: 0006-4971 Impact factor: 22.113